Are You Thinking of a Combination Therapy?

Our initial clinical studies will be as a single agent, but I think the world is moving towards combination therapies and inflammation indications. So we are planning on putting that into the clinic in the first part of next year. Right now internally, we have the capabilities for antibodies. And so for now, we're sticking with antibodies for our own internal programs, but in the future we may change that.